
Two senior leaders in the U.S. Food and Drug Administration’s vaccine review office are stepping down, but their departures won’t slow efforts to combat the pandemic, the agency said Tuesday. “We are confident in the expertise and ability of our staff to continue our critical public health work, including evaluating COVID-19 vaccines,” FDA spokesperson Stephanie… read on > read on >